Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension

Overview of attention for article published in Heart Failure Clinics, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 409)
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 52 X posts from 52 X users, with an upper bound of 68,084 followers.

RT @KessnerJp: Anticoagulation in Pulmonary Hypertension: evidence? https://t.co/akt2oIuEkN 🫁❤️‍🩹💘💊📚⁉️ @HeartFailureFrm @atscommunity @accp…

RT @georgepapadapol: Uso de anticoagulacion oral en Hipertensión Arterial Pulmonar:¿Con qué nivel de evidencia contamos? #HAP #VTE 👉 https…

RT @KessnerJp: Anticoagulation in Pulmonary Hypertension: evidence? https://t.co/akt2oIuEkN 🫁❤️‍🩹💘💊📚⁉️ @HeartFailureFrm @atscommunity @accp…

Uso de anticoagulacion oral en Hipertensión Arterial Pulmonar:¿Con qué nivel de evidencia contamos? #HAP #VTE 👉 https://t.co/yj8CDGJjsL https://t.co/hnwaCcyTZC

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 48 additional X posts.